US20040133261A1 - Sheath for self-expanding stents - Google Patents
Sheath for self-expanding stents Download PDFInfo
- Publication number
- US20040133261A1 US20040133261A1 US10/627,791 US62779103A US2004133261A1 US 20040133261 A1 US20040133261 A1 US 20040133261A1 US 62779103 A US62779103 A US 62779103A US 2004133261 A1 US2004133261 A1 US 2004133261A1
- Authority
- US
- United States
- Prior art keywords
- stent
- endoprosthesis
- sheath
- biocompatible material
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
- A61F2002/9511—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
- A61F2002/9583—Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0071—Additional features; Implant or prostheses properties not otherwise provided for breakable or frangible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Definitions
- This invention relates to apparatus and methods for the treatment of body lumens, and particularly to delivery systems for endoprostheses. More particularly, the invention relates to biocompatible and/or bioabsorbable sheaths for self-expanding stents. The present invention also is directed to a delivery system for self-expanding stents which facilitates minimal stent movement during deployment to achieve more accurate stent placement within the patient's vasculature.
- a guiding catheter having a preformed distal tip is percutaneously introduced over a first wire, such as a 0.035′′ wire, that has been placed in the vasculature through a guiding sheath into an artery and advanced within the cardiovascular system until the distal tip of the guiding catheter is seated in the ostium of a coronary artery.
- the first wire is removed and a guidewire, such as a 0.014′′ guidewire, is advanced distal to the treatment area.
- a dilatation catheter is back-loaded onto the guidewire and tracked to the treatment area through the guiding catheter.
- the balloon is inflated to a predetermined size with radiopaque liquid at relatively high pressure (e.g., greater than four atmospheres) to compress the plaque of the lesion and to otherwise expand the inner lumen of the artery.
- Stents are generally cylindrically shaped intravascular devices which are placed within an artery to hold it open.
- the device can be used to reduce the likelihood of restenosis and to maintain the patency of a blood vessel immediately after intravascular treatments. In some circumstances, they can also be used as the primary treatment device where they are expanded to dilate a stenosis and then left in place.
- Prior art stents typically fall into two general categories of construction.
- the first type of stent is expandable upon application of a controlled force, often through the inflation of the balloon portion of a dilatation catheter which, upon inflation of the balloon or other expansion means, expands the compressed stent to a larger diameter to be left in place within the artery at the target site.
- the second type of stent is a self-expanding stent, which may be formed from shape-memory metals such as super-elastic nickel titanium (NiTi) alloys which will automatically expand from a compressed state when the stent is advanced out of the distal end of the delivery catheter into the body lumen.
- Such self-expanding stents can typically be expanded without the need for application of a controlled force on the stent, such as is applied through the inflation of the balloon portion of a dilatation catheter.
- Such self-expanding stents may be manufactured from expandable heat-sensitive materials that allow for phase transformation of the materials to occur at set temperatures, resulting in the expansion and/or contraction of the stents.
- One method and system developed for delivering stents to desired locations within the patient's body lumen involves advancing the stent delivery system through the patient's vascular system until the stent is positioned within the treatment area, and then inflating the expandable member on the catheter to expand the stent within the blood vessel. The expandable member is then deflated and the catheter withdrawn, leaving the expanded stent within the blood vessel, holding open the passageway thereof.
- This approach is common with stents of the first type, i.e., stents that are not self-expanding.
- Implanting self-expanding stents within the patient's vasculature often require different methods than the one set forth above for non-self-expanding stents.
- Some prior art stent delivery systems for self-expanding stents include a catheter with an inner lumen upon which the compressed or collapsed stent is mounted, and an outer restraining sheath which is eventually placed over the compressed stent prior to deployment. When the stent is to be deployed in the body vessel, the outer sheath is moved in relation to the inner lumen to “uncover” the compressed stent, allowing the stent to move to its expanded condition.
- Some delivery systems utilize a “push-pull” technique in which the outer sheath is retractable while the inner sheath is pushed forward or held in place.
- Still other systems use an actuating wire which is attached to the outer sheath. When the actuating wire is pulled to retract the outer sheath over the collapsed stent, the inner lumen must remain stationary, preventing the stent from moving axially within the body vessel.
- the present invention is directed to a bio-compatible or bio-absorbable addition to a stent and/or stent delivery system. More particularly, the invention relates to a bio-compatible or bio-absorbable sheath, lining, or filament positioned on or in a stent.
- the bio-compatible or bio-absorbable material is designed to be implanted in the body along with the stent. After implantation, the material may be absorbed into the body, such as where the material is a bio-absorbable material that dissolves over a period of time.
- a bio-absorbable or bio-compatible filament is wound through or around an expandable stent.
- the filament may have sufficient strength to help in constraining the stent in an unexpanded configuration.
- Such a filament may still have sufficient weakness to permit the stent to be expanded via the application of a force, such as via the application of force provided by the expansion of a balloon catheter where the stent is positioned on the balloon. Expansion of the stent may be achieved by applying sufficient force to cause the filament to break or otherwise fail or relax.
- Expansion of the stent may be achieved by changing the configuration of the filament, such as by pulling or pushing, proximally or distally, on the filament until it no longer provides sufficient restraint to prevent the stent from expanding.
- the filament may be formed from various materials, including polymers.
- the filament may comprise one or more therapeutic agents, such as a drug useful in treating arterial walls.
- Such a filament may be bonded to the delivery catheter and/or the stent, such as where a polymer filament is heat-bonded in a tightly-coiled position around the stent.
- a polymer filament is heat-bonded in a tightly-coiled position around the stent.
- the bonding of the filament to the stent and/or delivery catheter may fail, in whole or in part, loosening the tightness of the filament around the stent and permitting the stent to expand.
- the filament maybe used to constrain self-expanding stents to prevent their expanding prior to the desired time and position for stent deployment.
- the filament may also be used with non-self-expanding stents, such as balloon-expandable stents, to help to retain the stent on a delivery system, such as a delivery catheter.
- the filament may also comprise and/or be used to deliver therapeutic agents, such as drugs or radiation therapy materials, or other materials that improve stent delivery, deployment, and/or performance, including materials that improve stent visibility under fluoroscopy or that facilitate radiation therapy.
- the bio-compatible and/or bio-absorbable material forms a sheath and/or coating that surrounds the stent, in whole or in part.
- the sheath and/or coating may have sufficient strength to help in constraining the stent in an unexpanded configuration, and may still have sufficient weakness to permit the stent to be expanded by applying sufficient force to cause the sheath to break or otherwise fail and/or relax.
- the sheath and/or coating may be formed from various materials, including polymers, and may comprise one or more therapeutic agents. In the case of a coating that is bonded to the stent, the coating may be applied to the inner or outer surface of the stent.
- the bio-compatible and/or bio-absorbable material is positioned in openings in the stent itself.
- the material may be positioned to fill one or more of the openings in an expandable stent pattern.
- the material may serve to prevent stent expansion by preventing the openings from changing shape.
- the material may serve as an adhesive that holds the sides of the opening in close proximity to one another, thereby preventing the stent from expanding.
- the material may be configured to fail or otherwise relax when sufficient force is applied to expand the stent, such as the force applied by inflation of a catheter balloon.
- FIG. 1 depicts, in cross-section, a partial side view of an embodiment of a catheter assembly, including stent and bio-compatible sheath of the present invention.
- FIG. 2 depicts, in cross-section, an end view of the embodiment of FIG. 1 of a catheter assembly of the present invention.
- FIG. 3 depicts a partial side view of the embodiment of FIG. 1 of a catheter assembly of the present invention.
- FIG. 4 depicts a partial side view of the catheter assembly of FIG. 3, wherein the balloon is expanded, thereby causing the bio-compatible sheath to fail and permit the stent to expand.
- FIG. 5 depicts a perspective view of a biocompatible sheath according to an embodiment of the invention.
- FIG. 6 depicts, in partial cross-section, a perspective view of a biocompatible sheath according to an embodiment of the invention.
- FIG. 7 depicts, in cross-section, a side view of a biocompatible sheath according to an embodiment of the invention.
- FIGS. 8 a - b depict perspective views of a biocompatible sheath according to an embodiment of the invention.
- FIG. 9 depicts a partial side view of an embodiment of a catheter assembly, including stent and bio-compatible filament of the present invention.
- FIG. 10 depicts a partial side view of the catheter assembly of FIG. 8, wherein the filament is relaxed and the stent is expanded.
- FIG. 11 depicts a view of a stent pattern, with bio-compatible material filling spaces within the stent pattern, in accordance with the stent in the unexpanded condition.
- FIG. 12 a depicts a perspective view of a stent portion with bio-compatible material within its spaces in accordance with an embodiment of the invention.
- FIG. 12 b depicts a perspective view of the stent portion of FIG. 12 a, with bio-compatible material within its spaces, wherein the stent is in an expanded condition.
- FIG. 13 a depicts a perspective view of stent having a coating of bio-compatible material in accordance with an embodiment of the invention.
- FIG. 13 b depicts a perspective view of stent having a coating of bio-compatible material in accordance with an embodiment of the invention.
- FIG. 14 depicts a partial side view of a stent delivery catheter assembly, including a stent and bio-compatible sheath of the present invention.
- FIG. 15 depicts a-partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, partially inserted within a patient's vessel (shown in cross-section).
- FIG. 16 depicts a partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, which has been positioned proximate to a dissected lining within a cross-section of a patient's vessel.
- FIG. 17 depicts a partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, which has been positioned proximate a dissected lining within a cross-section of a patient's vessel, wherein the balloon and stent are fully expanded and the bio-compatible sheath has failed and/or relaxed.
- FIG. 18 depicts a partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, wherein a stent and bio-compatible sheath have been deployed within a cross-section of a patient's vessel.
- the present invention is depicted in FIGS. 1 - 18 for use in various body lumens and procedures, including use in dilated arteries during balloon angioplasties.
- the stent may be used to ensure the patency of the body lumen in which it is implanted.
- the stent may be implanted in the coronary to reinforce the artery against recoil or to tack up a dissection in the arterial wall.
- the stent is useful for implanting in other blood vessels, such as the carotid arteries, illiacs, cerebral vasculature, and other peripheral veins and arteries.
- the present invention is not limited to use in blood vessels or angioplasties; but can be used in other body lumens and procedures, including treatment of urinary, digestive, or bile ducts.
- FIG. 1 depicts a catheter assembly 10 , including a delivery catheter 12 , an endoprosthesis (depicted as a stent 14 ), and a bio-compatible sheath 16 .
- the catheter assembly of the particular embodiment depicted includes an inner elongate tubular member 18 configured to encompass a guidewire 20 positioned to slide within an inner lumen of the inner elongate tubular member 18 .
- An outer catheter tube 22 is disposed on and secured to the inner elongate tubular member 18 .
- the catheter assembly 10 includes an expandable member, which in the embodiment depicted is a balloon 24 , formed on or secured to catheter tube 22 at the distal portion 26 of the catheter assembly 10
- the catheter tube further has a proximal portion 28 , which may include a sidearm 30 with an inflation port 32 in fluid communication with the catheter tube 22 , and may include a guidewire port 34 in communication with a proximal end 36 of the inner elongate tubular member 18 .
- the catheter tube 22 has a distal end 38 which is glued, bonded, heat shrunk, or otherwise secured to the inner elongate tubular member 18 near its distal end 38 .
- the expandable balloon 24 is formed just proximal of the distal end 38 of the catheter tube 22 .
- the expandable balloon 24 forms a part of the catheter tube 22 .
- the balloon 24 can be a separate element of the catheter assembly 10 , which may be secured to and in fluid communication with a lumen in the proximal portion of the catheter tube 22 .
- the inner elongate tubular member 18 may not be a necessary element of the catheter assembly, and the guidewire may be disposed within a separate lumen of the catheter tube.
- the stent 14 With the stent 14 positioned on the expandable balloon 24 , the stent 14 is crimped or otherwise disposed on the catheter tube 22 . As shown in FIG. 2, the non-solid, lattice nature of many of the present day stent configurations may result in a non-uniform application of the stent elements on the balloon. Furthermore, to reduce the overall profile of the catheter assembly, the expandable balloon may be folded such that the cross-section of the folded expandable balloon is not circular in nature. In many stent delivery catheters, the expandable member is a dilatation balloon having been arranged in a multiple-fold or no-fold configuration prior to positioning the stent on the balloon.
- the catheter assembly 10 includes a biocompatible sheath 16 , which is disposed over the endoprosthesis (stent) 14 .
- the sheath 16 is longitudinally shorter than the stent 14 .
- the sheath 16 is positioned with its distal end 42 and its proximal end 44 lying between the distal end 46 and proximal end 48 of the stent 14 .
- the sheath 16 also overlies the catheter balloon 24 , with the stent 14 positioned there between.
- the biocompatible sheath 16 at least partially surrounds the stent 14 , preventing the stent 14 from expanding, becoming dislodged from the catheter, or contacting the patient's vasculature during stent delivery.
- the biocompatible sheath 16 may resist outward pressure from the stent 14 , particularly where the stent is a self-expanding stent, to prevent the stent 14 from expanding or otherwise dislodging from the balloon 24 .
- the biocompatible sheath 16 may exert continuous inward pressure on the stent 14 .
- the length of the biocompatible sheath 16 can vary depending on the particular application and catheter assembly construction. For example, a longer biocompatible sheath may be used with longer stents, and a shorter sheath can be used with shorter stents.
- the biocompatible sheath maybe the same length of the stent, so that the proximal and distal ends of the sheath can align with proximal and distal ends of the stent, respectively, thereby covering the entire length of the stent when mounted on the catheter assembly.
- the sheath may be longer than the stent, so that it overlaps the distal and/or proximal ends of the stent when mounted on the catheter assembly.
- the biocompatible sheath maybe formed from various materials, including various formulations of polyurethane, silicon, siliconized polyurethane, PTFE, and siliconized PTFE.
- the biocompatible sheath may be formed partially or entirely of bioabsorbable materials, such as sucrose or polyethylene glycol.
- the biocompatible material may also comprise and/or be used to deliver therapeutic agents, such as drugs or radiation therapy materials, or other materials that improve stent delivery, deployment, and/or performance, including materials that improve stent visibility under fluoroscopy or that facilitate radiation therapy.
- the biocompatible sheath 16 is configured to fail, such as by stretching or tearing, upon expansion of the expandable balloon 24 of the catheter tube 22 .
- the sheath may be configured to fail at an inflation pressure of two atmospheres. Accordingly, the sheath 16 will fail well before the balloon 24 reaches its nominal pressure.
- the sheath 16 has a generally solid, consistent surface and cross-section.
- the sheath may have areas that are weaker than other portions, so that the sheath will fail at the weaker portions.
- the weakened portions can be created by softening the desired area of the sheath with heat, or otherwise deforming the structure of the sheath material at the desired location.
- the sheath 16 may have scoring 50 and/or one or more perforations 52 , as depicted in FIG. 5, so that the sheath will fail at the scored and/or perforated sections when it is expanded.
- the sheath may have thinned portions 54 that have thinner material than other portions of the sheath 16 , as depicted in FIG. 6, so that the sheath 16 when expanded will fail at the thinner portions 54 .
- the weakened areas may be selectively positioned about the sheath so that the sheath fails in a selected and controlled manner.
- the positioning of the weakened portions can assist in controlling stent deployment.
- the biocompatible sheath 16 may have areas of varying strength across its length, so that certain portions of the sheath will fail sooner than others.
- the biocompatible sheath 16 has varying strength along its length, which in the particular embodiment are achieved by having varying thicknesses 56 a - e along its length.
- the areas with the greatest thickness 56 a, 56 e are at the distal and proximal ends 42 , 44 of the sheath 16 , respectively.
- the sheath 16 is progressively thinner toward its center, with the area with the least thickness 56 c along the longitudinal center of the sheath 16 .
- the thickened and stronger proximal and distal portions of the sheath will resist stent expansion (and hence resist balloon expansion) with the greatest force.
- Such selective positioning of thicker portions can help to control uneven balloon and stent expansion, such as “dog-boning” where the distal and proximal portions of the balloon and stent are expanded prior to the central portions of the balloon and stent.
- the sheath 16 may be formed by rolling a planar portion 58 into a tubular member 60 .
- the planar portion 58 is held in the tubular shape by mechanical connections, which are scored and/or shaped arm elements 62 on a first end 64 of the planar portion 58 that interlock with openings 66 on an opposing second end 68 of the planar portion.
- the opposing ends 64 , 68 of the planar portion 58 may be held by other methods and devices, including other mechanical connections, heat bonding, and/or adhesives.
- FIG. 9 depicts another embodiment of the invention, with a catheter assembly 10 that includes a delivery catheter 12 , an endoprosthesis (depicted as a stent 14 ), and a bio-compatible filament 70 .
- the biocompatible filament 70 is wrapped around the stent, preventing the stent 14 from expanding or becoming dislodged from the catheter during stent delivery.
- the biocompatible sheath 16 may exert continuous inward pressure on the stent 14 , particularly where the stent is a self-expanding stent.
- the filament may be wrapped around the stent and, depending on the particular application and stent configuration, the filament may be woven through openings in the stent structure.
- the filament may be configured to fail or otherwise loosen its grip on the stent through various methods.
- the filament 70 may be configured to fail as pressure is applied, as where the balloon 24 is expanded to force the stent 14 to expand against the restraint of the filament 70 .
- the filament 70 of FIG. 9 may have areas that have been weakened, such as perforations, thinned areas, or other methods of weakening the filament structure.
- the filament 70 may be threaded or knotted about and/or through the stent so that, when sufficient pressure is applied (such as the pressure from an expanding balloon 24 ), the knotting and/or threading permits the filament to loosen its inward pressure on the stent, so that the stent is expanded as the filament loosens.
- the filament may also be secured, such as through heat bonding, to the stent, the balloon, the catheter, and/or to the filament itself, so that the securing device and/or method (e.g., the heat bond) will fail as the balloon is pressurized, thereby expanding the stent.
- a polymeric filament may wrapped around a stent on a catheter, and then the filament may be heat bonded to the stent.
- the wrapping of the filament in combination with the heat bond, can firmly hold the stent onto the balloon during stent delivery.
- the heat bonding will fail, causing the filament to loosen its hold on the stent and permitting the stent to expand.
- the filament 70 may be configured to fail through methods other than the application of expansion pressure such as that provided by the balloon and/or stent.
- the filament may be configured to loosen when a portion of the filament is pulled.
- FIG. 10 shows the catheter assembly 10 of FIG. 9, wherein the filament 70 has failed or otherwise loosened its hold, and the stent 14 is expanded.
- FIGS. 11 - 12 a further embodiment of the invention involves a stent 14 with an open-lattice configuration, with bio-compatible material 72 filling one or more of the open areas 74 within the stent pattern.
- FIG. 11 depicts the stent pattern two-dimensionally as if the tubular stent 14 were cut longitudinally and “unrolled” to form a flat sheet
- FIGS. 12 a - b depict a portion of the stent 14 in a perspective view.
- the pattern depicted includes a series of stent structures (depicted in the form of Us, Ws, and Ys), with vacated or open areas 74 between the stent structures.
- FIGS. 11 and 12 a depict the open-lattice stent 14 in the unexpanded condition, with open areas 74 in which biocompatible material 72 has been loaded.
- FIG. 12 b shows fractures 75 in the biocompatible material 72 in the open spaces 74 , created when the biocompatible material 72 in the open spaces 74 failed as pressure was applied to expand the stent 14 .
- FIG. 13 a shows a further embodiment of the invention, with the stent 14 having a coating 76 of bio-compatible material on the stent outer surface 78 .
- the coating 76 forms a shell on the outer surface of the stent 14 , which acts to prevent the stent 14 from expanding, becoming dislodged, and/or contacting the contacting the patient's vasculature during stent delivery.
- the coating 76 may be adhered to the outer surface of the stent 14 .
- portions of the coating 76 may extend into open areas of the stent 14 , such as with a stent having an open-lattice configuration.
- the biocompatible material that extends into the open areas of the stent 14 may provide further opposition to expansion of the stent.
- the stent 14 has the coating 76 of bio-compatible material on the stent inner surface 80 .
- the coating 76 forms a shell on the inner surface 80 of the stent 14 , which can act to prevent the stent 14 from expanding, becoming dislodged, and/or contacting the contacting the patient's vasculature during stent delivery.
- the bio-compatible material coating 76 on the inner surface 80 of the stent 14 may further improve stent retention during stent delivery where the bio-compatible material 76 has adhesive and/or non-slip properties that prevent the stent 14 from sliding along the balloon.
- the bio-compatible material coating 76 may serve to improve stent deployment by providing a smooth transition between the stent and a stent-deploying balloon as the balloon is expanded, which may involve unfolding of the balloon.
- the biocompatible material coating may help to smooth the inner surface of the stent after stent deployment, thereby providing a smoother lumen through which blood or other fluids can flow through the stent.
- the inner coating of FIG. 13 b may include portions of the coating 76 that extend into open areas of the stent 14 , providing further opposition to expansion of the stent.
- the outer and inner coatings of FIGS. 13 a and 13 b, respectively, may be used in combination.
- FIGS. 14 through 18 illustrate, by way of example, a method of delivering and implanting a stent 14 mounted on a balloon 24 of a catheter tube 22 , including an embodiment of the biocompatible sheath 16 .
- the drawing figures illustrate a rapid exchange (Rx) intravascular catheter
- embodiments of the retaining device may also be used with other delivery devices, including an over-the-wire (OTW) intravascular catheter.
- FIGS. 14 - 18 illustrate a situation in which the stent delivery system 10 having a biocompatible sheath 16 is used to deploy a stent 14 to support a dissected arterial lining to prevent the dissection 82 from collapsing into the arterial lumen 84 and impeding sufficient blood flow through the artery 86 .
- the procedures and devices described herein may be adapted by one of ordinary skill in the art to any procedure where an endoprosthesis is to be placed into a body lumen.
- a stent delivery assembly 10 is provided with biocompatible sheath 16 covering a stent 14 removably secured on an expandable member 24 formed on or secured to a catheter tube 22 .
- biocompatible sheath is depicted in FIGS. 14 - 18
- other biocompatible configurations such as the filaments, coatings, and inter-space materials of FIGS. 9 - 13 , may also be used in a procedure such as the one depicted in FIGS. 14 - 18 .
- the stent delivery assembly 10 is inserted into the lumen 84 of an artery 86 along a guidewire 20 having a distal end 88 , with the guidewire distal end 88 having been previously positioned past the dissection 82 requiring support.
- the expandable member 24 upon which the stent 14 and biocompatible sheath 16 are positioned, is then positioned proximate the dissection 82 , as depicted in FIG. 16.
- the expandable member (balloon) 24 of the catheter tube 22 is inflated. This may be accomplished, for example, by injecting inflation fluid under substantial pressure into a lumen of the catheter tube.
- a first pressure is realized, which is less than the nominal inflation pressure of the balloon, the biocompatible sheath 40 fails.
- the stent expands.
- the stent 14 expands until it is fully expanded and implanted in the artery 86 .
- the biocompatible sheath 16 is now positioned between the stent 14 and the arterial wall 90 .
- the expandable member 24 is contracted, such as may be achieved by deflating a catheter balloon.
- the delivery catheter 12 including the catheter tube 22 and expandable member 24 balloon
- guidewire 24 are withdrawn from the vasculature, as depicted in FIG. 18, with the stent 14 and biocompatible material (in the form of the sheath 16 ) remaining behind.
- the delivery catheter 12 can have an over-the-wire (OTW) or rapid exchange (Rx) configuration as more fully disclosed in, but not limited to, U.S. Pat. No. 4,323,071 (Simpson et al.) (OTW); U.S. Pat. No. 4,573,470 (Samson et al.) (OTW); U.S. Pat. No. 5,501,227 (Yock) (Rx); U.S. Pat. No. 5,061,273 (Yock) (Rx); and U.S. Pat. No. 5,496,346 (Horzewski et al.) (Rx).
- OW over-the-wire
- Rx rapid exchange
- the stent 14 can have various configurations, and suitable stents include, but are not limited to, the ACS MULTI-LINK STENT sold by Advanced Cardiovascular Systems, Inc., Santa Clara, Calif.; the NIR STENT sold by Boston Scientific, Natick, Mass.; and the MICRO STENT II and GFX sold by Arterial Vascular Engineering, Santa Rosa, Calif. Examples of suitable stents are disclosed in, but not limited to, U.S. Pat. No. 5,514,154 (Lau et al.).
- the dimensions of the intravascular catheter will generally follow the dimensions of intravascular catheters used in angioplasty procedures in the same arterial location.
- the length of a catheter assembly for use in the coronary arteries is about one hundred thirty-five to one hundred fifty centimeters
- the outer diameter of the catheter expandable member is about one millimeter
- the length of the balloon is typically about two centimeters
- the inflated diameter of the balloon is about one to about five millimeters, depending upon the application.
- Catheter dimensions for peripheral use will vary, as is known in the art.
- the materials of construction of the catheter assembly, catheter tube, and expandable member may be selected, for example, from those used in conventional balloon angioplasty catheters.
- the specific dimensions and materials of construction of the detachable sheath are provided as examples, and substitutes are readily contemplated which do not depart from the invention.
- the delivery catheter can also be employed to deliver stents and other endoprosthesis to locations within other body lumens.
- the biocompatible sheath may be used to cover and/or secure self-expanding and non-self-expanding stents on delivery catheters prior to deployment.
Abstract
A catheter assembly for delivering an endoprosthesis within a body lumen. A delivery catheter assembly is provided which includes a stent with biocompatible material thereon for preventing the stent from expanding or otherwise dislodging from the catheter. The stent with biocompatible material is secured to an expandable member of a delivery catheter, whereby inflation of the expandable member causes the biocompatible material to fail, thereby permitting the stent to expand and deploy in a body lumen.
Description
- The present application is a continuation in part of U.S. Ser. No. 09/632,741, filed Aug. 4, 2000, and entitled DETACHABLE SHEATH TO PROVIDE PRE-DEPLOYMENT STENT SECURITY AND ENHANCED DELIVERY PRECISION.
- This invention relates to apparatus and methods for the treatment of body lumens, and particularly to delivery systems for endoprostheses. More particularly, the invention relates to biocompatible and/or bioabsorbable sheaths for self-expanding stents. The present invention also is directed to a delivery system for self-expanding stents which facilitates minimal stent movement during deployment to achieve more accurate stent placement within the patient's vasculature.
- Several interventional treatment modalities are presently used for heart disease including balloon and laser angioplasty, atherectomy and by-pass surgery. In a typical cardiovascular intervention, a guiding catheter having a preformed distal tip is percutaneously introduced over a first wire, such as a 0.035″ wire, that has been placed in the vasculature through a guiding sheath into an artery and advanced within the cardiovascular system until the distal tip of the guiding catheter is seated in the ostium of a coronary artery. The first wire is removed and a guidewire, such as a 0.014″ guidewire, is advanced distal to the treatment area. Then a dilatation catheter is back-loaded onto the guidewire and tracked to the treatment area through the guiding catheter. Once in position across the lesion, the balloon is inflated to a predetermined size with radiopaque liquid at relatively high pressure (e.g., greater than four atmospheres) to compress the plaque of the lesion and to otherwise expand the inner lumen of the artery.
- Further details of dilatation catheters, guidewires, and devices associated therewith for angioplasty procedures have been known for a number of years, and by way of example, several forms of such devices can be found in U.S. Pat. No. 4,323,071 (Simpson-Robert); U.S. Pat. No. 4,439,185 (Lindquist); U.S. Pat. No. 4,516,972 (Samson); U.S. Pat. No. 4,538,622 (Samson, et al.); U.S. Pat. No. 4,554,929 (Samson, et al.); U.S. Pat. No. 4,616,652 (Simpson); U.S. Pat. No. 4,638,805 (Powell); U.S. Pat. No. 4,748,982 (Horzewski, et al.); U.S. Pat. No. 5,507,768 (Lau, et al.); U.S. Pat. No. 5,514,154 (Lau, et al.); U.S. Pat. No. 5,451,233 (Yock); and U.S. Pat. No. 5,458,615 (Klemm, et al.); and U.S. Pat. No. 5,700,286 (Tartaglia, et al.).
- A focus of recent development work in the treatment of heart disease has been directed to endoprosthetic devices called stents. Stents are generally cylindrically shaped intravascular devices which are placed within an artery to hold it open. The device can be used to reduce the likelihood of restenosis and to maintain the patency of a blood vessel immediately after intravascular treatments. In some circumstances, they can also be used as the primary treatment device where they are expanded to dilate a stenosis and then left in place.
- Prior art stents typically fall into two general categories of construction. The first type of stent is expandable upon application of a controlled force, often through the inflation of the balloon portion of a dilatation catheter which, upon inflation of the balloon or other expansion means, expands the compressed stent to a larger diameter to be left in place within the artery at the target site. The second type of stent is a self-expanding stent, which may be formed from shape-memory metals such as super-elastic nickel titanium (NiTi) alloys which will automatically expand from a compressed state when the stent is advanced out of the distal end of the delivery catheter into the body lumen. Such self-expanding stents can typically be expanded without the need for application of a controlled force on the stent, such as is applied through the inflation of the balloon portion of a dilatation catheter. Such self-expanding stents may be manufactured from expandable heat-sensitive materials that allow for phase transformation of the materials to occur at set temperatures, resulting in the expansion and/or contraction of the stents.
- One method and system developed for delivering stents to desired locations within the patient's body lumen involves advancing the stent delivery system through the patient's vascular system until the stent is positioned within the treatment area, and then inflating the expandable member on the catheter to expand the stent within the blood vessel. The expandable member is then deflated and the catheter withdrawn, leaving the expanded stent within the blood vessel, holding open the passageway thereof. This approach is common with stents of the first type, i.e., stents that are not self-expanding.
- Implanting self-expanding stents within the patient's vasculature often require different methods than the one set forth above for non-self-expanding stents. Some prior art stent delivery systems for self-expanding stents include a catheter with an inner lumen upon which the compressed or collapsed stent is mounted, and an outer restraining sheath which is eventually placed over the compressed stent prior to deployment. When the stent is to be deployed in the body vessel, the outer sheath is moved in relation to the inner lumen to “uncover” the compressed stent, allowing the stent to move to its expanded condition. Some delivery systems utilize a “push-pull” technique in which the outer sheath is retractable while the inner sheath is pushed forward or held in place. Still other systems use an actuating wire which is attached to the outer sheath. When the actuating wire is pulled to retract the outer sheath over the collapsed stent, the inner lumen must remain stationary, preventing the stent from moving axially within the body vessel.
- Because proper positioning of the stent is critical to the performance of the stent, it is imperative that the physician knows exactly where the stent will be placed upon deployment.
- What has been needed and heretofore unavailable is an improved device and method for accurately providing for release and deployment of stents, including self-expanding stents. The present invention satisfies these and other needs.
- Briefly, and in general terms, the present invention is directed to a bio-compatible or bio-absorbable addition to a stent and/or stent delivery system. More particularly, the invention relates to a bio-compatible or bio-absorbable sheath, lining, or filament positioned on or in a stent. The bio-compatible or bio-absorbable material is designed to be implanted in the body along with the stent. After implantation, the material may be absorbed into the body, such as where the material is a bio-absorbable material that dissolves over a period of time.
- In one embodiment of the invention, a bio-absorbable or bio-compatible filament is wound through or around an expandable stent. The filament may have sufficient strength to help in constraining the stent in an unexpanded configuration. Such a filament may still have sufficient weakness to permit the stent to be expanded via the application of a force, such as via the application of force provided by the expansion of a balloon catheter where the stent is positioned on the balloon. Expansion of the stent may be achieved by applying sufficient force to cause the filament to break or otherwise fail or relax. Expansion of the stent may be achieved by changing the configuration of the filament, such as by pulling or pushing, proximally or distally, on the filament until it no longer provides sufficient restraint to prevent the stent from expanding. The filament may be formed from various materials, including polymers. The filament may comprise one or more therapeutic agents, such as a drug useful in treating arterial walls.
- Such a filament may be bonded to the delivery catheter and/or the stent, such as where a polymer filament is heat-bonded in a tightly-coiled position around the stent. During stent deployment, which may be achieved through inflation of a balloon catheter, the bonding of the filament to the stent and/or delivery catheter may fail, in whole or in part, loosening the tightness of the filament around the stent and permitting the stent to expand.
- The filament maybe used to constrain self-expanding stents to prevent their expanding prior to the desired time and position for stent deployment. The filament may also be used with non-self-expanding stents, such as balloon-expandable stents, to help to retain the stent on a delivery system, such as a delivery catheter. The filament may also comprise and/or be used to deliver therapeutic agents, such as drugs or radiation therapy materials, or other materials that improve stent delivery, deployment, and/or performance, including materials that improve stent visibility under fluoroscopy or that facilitate radiation therapy.
- In a further embodiment of the invention, the bio-compatible and/or bio-absorbable material forms a sheath and/or coating that surrounds the stent, in whole or in part. Like the filament, the sheath and/or coating may have sufficient strength to help in constraining the stent in an unexpanded configuration, and may still have sufficient weakness to permit the stent to be expanded by applying sufficient force to cause the sheath to break or otherwise fail and/or relax. The sheath and/or coating may be formed from various materials, including polymers, and may comprise one or more therapeutic agents. In the case of a coating that is bonded to the stent, the coating may be applied to the inner or outer surface of the stent.
- In a further embodiment of the invention, the bio-compatible and/or bio-absorbable material is positioned in openings in the stent itself. For example, the material may be positioned to fill one or more of the openings in an expandable stent pattern. In stents that require such openings to change shape during stent expansion, the material may serve to prevent stent expansion by preventing the openings from changing shape. For example, the material may serve as an adhesive that holds the sides of the opening in close proximity to one another, thereby preventing the stent from expanding. The material may be configured to fail or otherwise relax when sufficient force is applied to expand the stent, such as the force applied by inflation of a catheter balloon.
- Other features and advantages of the invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate, by way of example, the features of the invention.
- FIG. 1 depicts, in cross-section, a partial side view of an embodiment of a catheter assembly, including stent and bio-compatible sheath of the present invention.
- FIG. 2 depicts, in cross-section, an end view of the embodiment of FIG. 1 of a catheter assembly of the present invention.
- FIG. 3 depicts a partial side view of the embodiment of FIG. 1 of a catheter assembly of the present invention.
- FIG. 4 depicts a partial side view of the catheter assembly of FIG. 3, wherein the balloon is expanded, thereby causing the bio-compatible sheath to fail and permit the stent to expand.
- FIG. 5 depicts a perspective view of a biocompatible sheath according to an embodiment of the invention.
- FIG. 6 depicts, in partial cross-section, a perspective view of a biocompatible sheath according to an embodiment of the invention.
- FIG. 7 depicts, in cross-section, a side view of a biocompatible sheath according to an embodiment of the invention.
- FIGS. 8a-b depict perspective views of a biocompatible sheath according to an embodiment of the invention.
- FIG. 9 depicts a partial side view of an embodiment of a catheter assembly, including stent and bio-compatible filament of the present invention.
- FIG. 10 depicts a partial side view of the catheter assembly of FIG. 8, wherein the filament is relaxed and the stent is expanded.
- FIG. 11 depicts a view of a stent pattern, with bio-compatible material filling spaces within the stent pattern, in accordance with the stent in the unexpanded condition.
- FIG. 12a depicts a perspective view of a stent portion with bio-compatible material within its spaces in accordance with an embodiment of the invention.
- FIG. 12b depicts a perspective view of the stent portion of FIG. 12a, with bio-compatible material within its spaces, wherein the stent is in an expanded condition.
- FIG. 13a depicts a perspective view of stent having a coating of bio-compatible material in accordance with an embodiment of the invention.
- FIG. 13b depicts a perspective view of stent having a coating of bio-compatible material in accordance with an embodiment of the invention.
- FIG. 14 depicts a partial side view of a stent delivery catheter assembly, including a stent and bio-compatible sheath of the present invention.
- FIG. 15 depicts a-partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, partially inserted within a patient's vessel (shown in cross-section).
- FIG. 16 depicts a partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, which has been positioned proximate to a dissected lining within a cross-section of a patient's vessel.
- FIG. 17 depicts a partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, which has been positioned proximate a dissected lining within a cross-section of a patient's vessel, wherein the balloon and stent are fully expanded and the bio-compatible sheath has failed and/or relaxed.
- FIG. 18 depicts a partial side view of the stent delivery catheter assembly of FIG. 14, including a stent and bio-compatible material of the present invention, wherein a stent and bio-compatible sheath have been deployed within a cross-section of a patient's vessel.
- The present invention is depicted in FIGS.1-18 for use in various body lumens and procedures, including use in dilated arteries during balloon angioplasties. The stent may be used to ensure the patency of the body lumen in which it is implanted. For example, the stent may be implanted in the coronary to reinforce the artery against recoil or to tack up a dissection in the arterial wall. The stent is useful for implanting in other blood vessels, such as the carotid arteries, illiacs, cerebral vasculature, and other peripheral veins and arteries. However, the present invention is not limited to use in blood vessels or angioplasties; but can be used in other body lumens and procedures, including treatment of urinary, digestive, or bile ducts.
- FIG. 1 depicts a
catheter assembly 10, including adelivery catheter 12, an endoprosthesis (depicted as a stent 14), and abio-compatible sheath 16. The catheter assembly of the particular embodiment depicted includes an inner elongatetubular member 18 configured to encompass aguidewire 20 positioned to slide within an inner lumen of the inner elongatetubular member 18. Anouter catheter tube 22 is disposed on and secured to the inner elongatetubular member 18. Thecatheter assembly 10 includes an expandable member, which in the embodiment depicted is aballoon 24, formed on or secured tocatheter tube 22 at thedistal portion 26 of thecatheter assembly 10 The catheter tube further has aproximal portion 28, which may include asidearm 30 with aninflation port 32 in fluid communication with thecatheter tube 22, and may include aguidewire port 34 in communication with aproximal end 36 of the inner elongatetubular member 18. In addition, thecatheter tube 22 has adistal end 38 which is glued, bonded, heat shrunk, or otherwise secured to the inner elongatetubular member 18 near itsdistal end 38. - The
expandable balloon 24 is formed just proximal of thedistal end 38 of thecatheter tube 22. In the embodiment of FIG. 1, theexpandable balloon 24 forms a part of thecatheter tube 22. Alternatively, theballoon 24 can be a separate element of thecatheter assembly 10, which may be secured to and in fluid communication with a lumen in the proximal portion of thecatheter tube 22. In such a configuration, the inner elongatetubular member 18 may not be a necessary element of the catheter assembly, and the guidewire may be disposed within a separate lumen of the catheter tube. - With the
stent 14 positioned on theexpandable balloon 24, thestent 14 is crimped or otherwise disposed on thecatheter tube 22. As shown in FIG. 2, the non-solid, lattice nature of many of the present day stent configurations may result in a non-uniform application of the stent elements on the balloon. Furthermore, to reduce the overall profile of the catheter assembly, the expandable balloon may be folded such that the cross-section of the folded expandable balloon is not circular in nature. In many stent delivery catheters, the expandable member is a dilatation balloon having been arranged in a multiple-fold or no-fold configuration prior to positioning the stent on the balloon. - The
catheter assembly 10 includes abiocompatible sheath 16, which is disposed over the endoprosthesis (stent) 14. In the embodiment of FIG. 1, thesheath 16 is longitudinally shorter than thestent 14. Thesheath 16 is positioned with itsdistal end 42 and itsproximal end 44 lying between thedistal end 46 andproximal end 48 of thestent 14. Thesheath 16 also overlies thecatheter balloon 24, with thestent 14 positioned there between. Thebiocompatible sheath 16 at least partially surrounds thestent 14, preventing thestent 14 from expanding, becoming dislodged from the catheter, or contacting the patient's vasculature during stent delivery. Thebiocompatible sheath 16 may resist outward pressure from thestent 14, particularly where the stent is a self-expanding stent, to prevent thestent 14 from expanding or otherwise dislodging from theballoon 24. Depending on the particular application, thebiocompatible sheath 16 may exert continuous inward pressure on thestent 14. - The length of the
biocompatible sheath 16 can vary depending on the particular application and catheter assembly construction. For example, a longer biocompatible sheath may be used with longer stents, and a shorter sheath can be used with shorter stents. The biocompatible sheath maybe the same length of the stent, so that the proximal and distal ends of the sheath can align with proximal and distal ends of the stent, respectively, thereby covering the entire length of the stent when mounted on the catheter assembly. The sheath may be longer than the stent, so that it overlaps the distal and/or proximal ends of the stent when mounted on the catheter assembly. - The biocompatible sheath maybe formed from various materials, including various formulations of polyurethane, silicon, siliconized polyurethane, PTFE, and siliconized PTFE. The biocompatible sheath may be formed partially or entirely of bioabsorbable materials, such as sucrose or polyethylene glycol. The biocompatible material may also comprise and/or be used to deliver therapeutic agents, such as drugs or radiation therapy materials, or other materials that improve stent delivery, deployment, and/or performance, including materials that improve stent visibility under fluoroscopy or that facilitate radiation therapy.
- Referring to FIGS.3-4, the
biocompatible sheath 16 is configured to fail, such as by stretching or tearing, upon expansion of theexpandable balloon 24 of thecatheter tube 22. Depending on the application, it may be preferable for thebiocompatible sheath 16 to fail at a pressure lower than that of a nominal inflation pressure of theballoon 24, where the nominal inflation pressure is the pressure at which the balloon would, without restraint such as that provided by a biocompatible sheath, reach a specified diameter. For example, with a balloon having a nominal inflation pressure of 8 atmospheres, the sheath may be configured to fail at an inflation pressure of two atmospheres. Accordingly, thesheath 16 will fail well before theballoon 24 reaches its nominal pressure. - As shown in FIG. 4, introduction of inflation fluid (air, saline, etc.) into the
catheter tube 22 causes theexpandable member 24 to expand radially outwardly. The expansion of theexpandable member 24 expands thestent 14, causing thebiocompatible sheath 16 to fail. In the embodiment of FIG. 4, thebiocompatible sheath 16 fails by plastically deforming. Once theballoon 24 is fully expanded, thestent 14 also becomes fully expanded, with thebiocompatible sheath 16 remaining on thestent 14. - In the embodiment depicted in FIGS.3-4, the
sheath 16 has a generally solid, consistent surface and cross-section. In additional embodiments, the sheath may have areas that are weaker than other portions, so that the sheath will fail at the weaker portions. The weakened portions can be created by softening the desired area of the sheath with heat, or otherwise deforming the structure of the sheath material at the desired location. For example, thesheath 16 may have scoring 50 and/or one ormore perforations 52, as depicted in FIG. 5, so that the sheath will fail at the scored and/or perforated sections when it is expanded. - The sheath may have thinned
portions 54 that have thinner material than other portions of thesheath 16, as depicted in FIG. 6, so that thesheath 16 when expanded will fail at thethinner portions 54. - The weakened areas (e.g., scoring50,
perforations 52, and/or thinner portions 54) may be selectively positioned about the sheath so that the sheath fails in a selected and controlled manner. Depending on the particular application and sheath configuration, the positioning of the weakened portions can assist in controlling stent deployment. For example, thebiocompatible sheath 16 may have areas of varying strength across its length, so that certain portions of the sheath will fail sooner than others. In the embodiment depicted in FIG. 7, thebiocompatible sheath 16 has varying strength along its length, which in the particular embodiment are achieved by having varying thicknesses 56 a-e along its length. The areas with the greatest thickness 56 a, 56 e are at the distal and proximal ends 42, 44 of thesheath 16, respectively. Thesheath 16 is progressively thinner toward its center, with the area with the least thickness 56 c along the longitudinal center of thesheath 16. The thickened and stronger proximal and distal portions of the sheath will resist stent expansion (and hence resist balloon expansion) with the greatest force. Such selective positioning of thicker portions can help to control uneven balloon and stent expansion, such as “dog-boning” where the distal and proximal portions of the balloon and stent are expanded prior to the central portions of the balloon and stent. - In a further embodiment depicted in FIGS. 8a-b, the
sheath 16 may be formed by rolling aplanar portion 58 into atubular member 60. In the embodiment depicted, theplanar portion 58 is held in the tubular shape by mechanical connections, which are scored and/or shapedarm elements 62 on afirst end 64 of theplanar portion 58 that interlock withopenings 66 on an opposingsecond end 68 of the planar portion. Depending on the particular application, the opposing ends 64, 68 of theplanar portion 58 may be held by other methods and devices, including other mechanical connections, heat bonding, and/or adhesives. - FIG. 9 depicts another embodiment of the invention, with a
catheter assembly 10 that includes adelivery catheter 12, an endoprosthesis (depicted as a stent 14), and abio-compatible filament 70. Thebiocompatible filament 70 is wrapped around the stent, preventing thestent 14 from expanding or becoming dislodged from the catheter during stent delivery. Thebiocompatible sheath 16 may exert continuous inward pressure on thestent 14, particularly where the stent is a self-expanding stent. The filament may be wrapped around the stent and, depending on the particular application and stent configuration, the filament may be woven through openings in the stent structure. - The filament may be configured to fail or otherwise loosen its grip on the stent through various methods. For example, the
filament 70 may be configured to fail as pressure is applied, as where theballoon 24 is expanded to force thestent 14 to expand against the restraint of thefilament 70. As with thesheaths 16 described previously with respect to FIGS. 1-8, thefilament 70 of FIG. 9 may have areas that have been weakened, such as perforations, thinned areas, or other methods of weakening the filament structure. Thefilament 70 may be threaded or knotted about and/or through the stent so that, when sufficient pressure is applied (such as the pressure from an expanding balloon 24), the knotting and/or threading permits the filament to loosen its inward pressure on the stent, so that the stent is expanded as the filament loosens. The filament may also be secured, such as through heat bonding, to the stent, the balloon, the catheter, and/or to the filament itself, so that the securing device and/or method (e.g., the heat bond) will fail as the balloon is pressurized, thereby expanding the stent. For example, a polymeric filament may wrapped around a stent on a catheter, and then the filament may be heat bonded to the stent. The wrapping of the filament, in combination with the heat bond, can firmly hold the stent onto the balloon during stent delivery. When the balloon is pressurized during stent deployment, the heat bonding will fail, causing the filament to loosen its hold on the stent and permitting the stent to expand. - The
filament 70 may be configured to fail through methods other than the application of expansion pressure such as that provided by the balloon and/or stent. For example, the filament may be configured to loosen when a portion of the filament is pulled. FIG. 10 shows thecatheter assembly 10 of FIG. 9, wherein thefilament 70 has failed or otherwise loosened its hold, and thestent 14 is expanded. - Referring now to FIGS.11-12, a further embodiment of the invention involves a
stent 14 with an open-lattice configuration, withbio-compatible material 72 filling one or more of theopen areas 74 within the stent pattern. FIG. 11 depicts the stent pattern two-dimensionally as if thetubular stent 14 were cut longitudinally and “unrolled” to form a flat sheet, while FIGS. 12a-b depict a portion of thestent 14 in a perspective view. The pattern depicted includes a series of stent structures (depicted in the form of Us, Ws, and Ys), with vacated oropen areas 74 between the stent structures. FIGS. 11 and 12a depict the open-lattice stent 14 in the unexpanded condition, withopen areas 74 in whichbiocompatible material 72 has been loaded. - As depicted in FIG. 12b, when an open-
lattice stent 14 such as the one depicted is expanded, theopen areas 74 deform in shape. Thebiocompatible material 72 loaded in theopen areas 74 resists such deformation of theopen areas 74, thereby preventing thestent 14 from expanding. For example, thebio-compatible material 72 may serve as an adhesive that holds together the stent structure surrounding theopen areas 74, thereby preventing thestent 14 from expanding. Thebiocompatible material 72 may be configured to fail or otherwise relax when sufficient force is applied to expand thestent 14, such as the force applied by inflation of a catheter balloon upon which the stent is mounted. FIG. 12b showsfractures 75 in thebiocompatible material 72 in theopen spaces 74, created when thebiocompatible material 72 in theopen spaces 74 failed as pressure was applied to expand thestent 14. - FIG. 13a shows a further embodiment of the invention, with the
stent 14 having acoating 76 of bio-compatible material on the stentouter surface 78. Thecoating 76 forms a shell on the outer surface of thestent 14, which acts to prevent thestent 14 from expanding, becoming dislodged, and/or contacting the contacting the patient's vasculature during stent delivery. Thecoating 76 may be adhered to the outer surface of thestent 14. Depending on the particular application, portions of thecoating 76 may extend into open areas of thestent 14, such as with a stent having an open-lattice configuration. As discussed above with respect to FIGS. 11-12, the biocompatible material that extends into the open areas of thestent 14 may provide further opposition to expansion of the stent. - In FIG. 13b the
stent 14 has thecoating 76 of bio-compatible material on the stentinner surface 80. Thecoating 76 forms a shell on theinner surface 80 of thestent 14, which can act to prevent thestent 14 from expanding, becoming dislodged, and/or contacting the contacting the patient's vasculature during stent delivery. Thebio-compatible material coating 76 on theinner surface 80 of thestent 14 may further improve stent retention during stent delivery where thebio-compatible material 76 has adhesive and/or non-slip properties that prevent thestent 14 from sliding along the balloon. Thebio-compatible material coating 76 may serve to improve stent deployment by providing a smooth transition between the stent and a stent-deploying balloon as the balloon is expanded, which may involve unfolding of the balloon. The biocompatible material coating may help to smooth the inner surface of the stent after stent deployment, thereby providing a smoother lumen through which blood or other fluids can flow through the stent. As was the case with the outer coating of FIG. 13a, the inner coating of FIG. 13b may include portions of thecoating 76 that extend into open areas of thestent 14, providing further opposition to expansion of the stent. The outer and inner coatings of FIGS. 13a and 13 b, respectively, may be used in combination. - FIGS. 14 through 18 illustrate, by way of example, a method of delivering and implanting a
stent 14 mounted on aballoon 24 of acatheter tube 22, including an embodiment of thebiocompatible sheath 16. While the drawing figures illustrate a rapid exchange (Rx) intravascular catheter, embodiments of the retaining device may also be used with other delivery devices, including an over-the-wire (OTW) intravascular catheter. FIGS. 14-18 illustrate a situation in which thestent delivery system 10 having abiocompatible sheath 16 is used to deploy astent 14 to support a dissected arterial lining to prevent thedissection 82 from collapsing into thearterial lumen 84 and impeding sufficient blood flow through theartery 86. Furthermore, the procedures and devices described herein may be adapted by one of ordinary skill in the art to any procedure where an endoprosthesis is to be placed into a body lumen. - As shown in FIG. 14, a
stent delivery assembly 10 is provided withbiocompatible sheath 16 covering astent 14 removably secured on anexpandable member 24 formed on or secured to acatheter tube 22. Note that while a biocompatible sheath is depicted in FIGS. 14-18, other biocompatible configurations, such as the filaments, coatings, and inter-space materials of FIGS. 9-13, may also be used in a procedure such as the one depicted in FIGS. 14-18. Referring to FIG. 15, thestent delivery assembly 10 is inserted into thelumen 84 of anartery 86 along aguidewire 20 having adistal end 88, with the guidewiredistal end 88 having been previously positioned past thedissection 82 requiring support. Theexpandable member 24, upon which thestent 14 andbiocompatible sheath 16 are positioned, is then positioned proximate thedissection 82, as depicted in FIG. 16. - As illustrated in FIG. 17, once the
expandable member 24 andstent 14 are positioned at thedissection 82, the expandable member (balloon) 24 of thecatheter tube 22 is inflated. This may be accomplished, for example, by injecting inflation fluid under substantial pressure into a lumen of the catheter tube. Once a first pressure is realized, which is less than the nominal inflation pressure of the balloon, thebiocompatible sheath 40 fails. As the biocompatible sheath fails, the stent expands. As theballoon 24 continues to expand to its nominal (second) pressure, thestent 14 expands until it is fully expanded and implanted in theartery 86. Thebiocompatible sheath 16 is now positioned between thestent 14 and thearterial wall 90. - After the
stent 14 is fully expanded, theexpandable member 24 is contracted, such as may be achieved by deflating a catheter balloon. The delivery catheter 12 (including thecatheter tube 22 andexpandable member 24 balloon) andguidewire 24 are withdrawn from the vasculature, as depicted in FIG. 18, with thestent 14 and biocompatible material (in the form of the sheath 16) remaining behind. - As discussed above, the
delivery catheter 12, as described herein, can have an over-the-wire (OTW) or rapid exchange (Rx) configuration as more fully disclosed in, but not limited to, U.S. Pat. No. 4,323,071 (Simpson et al.) (OTW); U.S. Pat. No. 4,573,470 (Samson et al.) (OTW); U.S. Pat. No. 5,501,227 (Yock) (Rx); U.S. Pat. No. 5,061,273 (Yock) (Rx); and U.S. Pat. No. 5,496,346 (Horzewski et al.) (Rx). Likewise, thestent 14, as described herein, can have various configurations, and suitable stents include, but are not limited to, the ACS MULTI-LINK STENT sold by Advanced Cardiovascular Systems, Inc., Santa Clara, Calif.; the NIR STENT sold by Boston Scientific, Natick, Mass.; and the MICRO STENT II and GFX sold by Arterial Vascular Engineering, Santa Rosa, Calif. Examples of suitable stents are disclosed in, but not limited to, U.S. Pat. No. 5,514,154 (Lau et al.). - The dimensions of the intravascular catheter will generally follow the dimensions of intravascular catheters used in angioplasty procedures in the same arterial location. Typically, the length of a catheter assembly for use in the coronary arteries is about one hundred thirty-five to one hundred fifty centimeters, the outer diameter of the catheter expandable member is about one millimeter, the length of the balloon is typically about two centimeters, and the inflated diameter of the balloon is about one to about five millimeters, depending upon the application. Catheter dimensions for peripheral use will vary, as is known in the art. The materials of construction of the catheter assembly, catheter tube, and expandable member may be selected, for example, from those used in conventional balloon angioplasty catheters. Furthermore, the specific dimensions and materials of construction of the detachable sheath are provided as examples, and substitutes are readily contemplated which do not depart from the invention.
- While the present invention has been described herein in terms of delivering an expandable stent to a desired location within a patient's blood vessel, the delivery catheter can also be employed to deliver stents and other endoprosthesis to locations within other body lumens. In addition, the biocompatible sheath may be used to cover and/or secure self-expanding and non-self-expanding stents on delivery catheters prior to deployment.
- Although preferred and alternative embodiments of the invention have been described and illustrated, the invention is susceptible to modifications and adaptations within the ability of those skilled in the art and without the exercise of inventive faculty. Thus, it should be understood that various changes in form, detail, and usage of the present invention may be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
Claims (19)
1. A catheter assembly for delivering an endoprosthesis within a body lumen, comprising:
a catheter;
an expandable member;
an endoprosthesis disposed on the expandable member; and
a biocompatible material positioned on the endoprosthesis, wherein the biocompatible material is configured to prevent expansion of the endoprosthesis.
2. The catheter assembly of claim 1 , wherein the endoprosthesis is a self-expanding stent, and the biocompatible material provides inward pressure on the self-expanding stent to prevent expansion of the self-expanding stent.
3. The catheter assembly of claim 1 , wherein the biocompatible material comprises a sheath that surrounds at least a portion of the endoprosthesis.
4. The catheter assembly of claim 3 , wherein the sheath has a length less than a length of the stent, the stent has a distal end and a proximal end, and the sheath is positioned on the stent so that the sheath does not overlie the distal end or proximal end of the stent.
5. The catheter assembly of claim 1 , wherein the biocompatible material comprises a filament that is wrapped around at least a portion of the endoprosthesis.
6. The catheter assembly of claim 5 , wherein the stent has an open-lattice configuration with open areas, and the filament is threaded through one or more of the open areas of the stent.
7. The catheter assembly of claim 5 , wherein the filament is heat bonded to the stent.
8. The catheter assembly of claim 1 , wherein the biocompatible material comprises a coating on the stent.
9. The catheter assembly of claim 8 , wherein the stent has an outer surface, and the biocompatible coating is positioned on the outer surface of the stent.
10. The catheter assembly of claim 8 , wherein the stent has an inner surface, and the biocompatible coating is positioned on the inner surface of the stent.
11. The catheter assembly of claim 1 , wherein the stent has open areas, and the biocompatible material is positioned within one or more of said open areas of the stent.
12. An endoprosthesis for deployment in a body lumen, comprising:
a stent; and
a biocompatible material positioned on the endoprosthesis, wherein the biocompatible material is configured to prevent expansion of the endoprosthesis.
13. The endoprosthesis of claim 12 , wherein the stent is a self-expanding stent.
14. The endoprosthesis of claim 13 , wherein the stent comprises one or more open areas, and the biocompatible material is positioned within one or more of the open areas.
15. The endoprosthesis of claim 12 , wherein the biocompatible material comprises a sheath positioned to surround at least a portion of the stent.
16. The endoprosthesis of claim 12 , wherein the biocompatible material comprises a filament wrapped around the stent.
17. The endoprosthesis of claim 16 , wherein the filament is heat-bonded to the stent.
18. The endoprosthesis of claim 12 , wherein the stent has one or more open areas, and the biocompatible material comprises a filament threaded through one or more of the open areas of the stent.
19. A method of delivering an endoprosthesis into a desired location within a body lumen, the method comprising:
providing a catheter assembly including a catheter, an expandable member, an endoprosthesis disposed on the expandable member, and a biocompatible material positioned on the endoprosthesis, wherein the biocompatible material is configured to prevent expansion of the endoprosthesis but also to fail under sufficient pressure;
advancing the catheter, the expandable member, and the endoprosthesis through the body lumen;
positioning the expandable member and endoprosthesis at a desired location;
deploying the endoprosthesis and biocompatible material at the desired location, including the step of expanding the expandable member so as to cause the biocompatible material to fail and the endoprosthesis to expand;
contracting the expandable member;
withdrawing the catheter, the expandable member, and the sheath from the body lumen; and
leaving the endoprosthesis and biocompatible material at the desired location within the body lumen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/627,791 US20040133261A1 (en) | 2000-08-04 | 2003-07-25 | Sheath for self-expanding stents |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63274100A | 2000-08-04 | 2000-08-04 | |
US09/897,743 US6629992B2 (en) | 2000-08-04 | 2001-06-29 | Sheath for self-expanding stent |
US10/627,791 US20040133261A1 (en) | 2000-08-04 | 2003-07-25 | Sheath for self-expanding stents |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/897,743 Division US6629992B2 (en) | 2000-08-04 | 2001-06-29 | Sheath for self-expanding stent |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040133261A1 true US20040133261A1 (en) | 2004-07-08 |
Family
ID=24536751
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/897,743 Expired - Lifetime US6629992B2 (en) | 2000-08-04 | 2001-06-29 | Sheath for self-expanding stent |
US10/627,791 Abandoned US20040133261A1 (en) | 2000-08-04 | 2003-07-25 | Sheath for self-expanding stents |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/897,743 Expired - Lifetime US6629992B2 (en) | 2000-08-04 | 2001-06-29 | Sheath for self-expanding stent |
Country Status (1)
Country | Link |
---|---|
US (2) | US6629992B2 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060116748A1 (en) * | 2003-04-14 | 2006-06-01 | Aaron Kaplan | Stepped balloon catheter for treating vascular bifurcations |
US20070276460A1 (en) * | 2003-04-14 | 2007-11-29 | Davis H R | Helical ostium support for treating vascular bifurcations |
US20080015678A1 (en) * | 2004-10-13 | 2008-01-17 | Tryton Medical, Inc. | Prosthesis for placement at a luminal os |
US20090018635A1 (en) * | 2007-07-10 | 2009-01-15 | Boston Scientific Scimed, Inc. | Stent protector |
US7731747B2 (en) | 2003-04-14 | 2010-06-08 | Tryton Medical, Inc. | Vascular bifurcation prosthesis with multiple thin fronds |
US20100204770A1 (en) * | 2009-02-10 | 2010-08-12 | Medtronic Vascular, Inc. | Stent Delivery System Permitting in Vivo Stent Repositioning |
US20100234934A1 (en) * | 2009-03-10 | 2010-09-16 | Medtronic Vascular, Inc. | Balloon Deployable Coronary Stent |
US7972372B2 (en) | 2003-04-14 | 2011-07-05 | Tryton Medical, Inc. | Kit for treating vascular bifurcations |
US8083791B2 (en) | 2003-04-14 | 2011-12-27 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
WO2012078769A1 (en) * | 2010-12-07 | 2012-06-14 | Northeastern University | Microvascular anastomotic coupler and methods of using the same |
US8366763B2 (en) | 2009-07-02 | 2013-02-05 | Tryton Medical, Inc. | Ostium support for treating vascular bifurcations |
WO2017004209A1 (en) * | 2015-06-29 | 2017-01-05 | 480 Biomedical, Inc. | Scaffold loading and delivery systems |
US9707108B2 (en) | 2010-11-24 | 2017-07-18 | Tryton Medical, Inc. | Support for treating vascular bifurcations |
US9956103B2 (en) | 2013-03-11 | 2018-05-01 | DePuy Synthes Products, Inc. | Stent delivery system and method |
US10111767B2 (en) | 2010-10-29 | 2018-10-30 | Abbott Cardiovascular Systems Inc. | Sheaths used in polymer scaffold delivery systems |
US10172734B2 (en) | 2013-03-13 | 2019-01-08 | DePuy Synthes Products, Inc. | Capture tube mechanism for delivering and releasing a stent |
US10232147B2 (en) | 2011-05-27 | 2019-03-19 | Abbott Cardiovascular Systems Inc. | Method for assembling a scaffold-balloon catheter |
US10433996B2 (en) | 2014-03-13 | 2019-10-08 | Abbott Cardiovascular Systems Inc. | Striped sheaths for medical devices |
US10470907B2 (en) | 2011-06-21 | 2019-11-12 | Abbott Cardiovascular Systems Inc. | Sheaths used with polymer scaffolds |
US10500077B2 (en) | 2012-04-26 | 2019-12-10 | Poseidon Medical Inc. | Support for treating vascular bifurcations |
WO2020179697A1 (en) * | 2019-03-06 | 2020-09-10 | 川澄化学工業株式会社 | Stent |
Families Citing this family (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1447058A1 (en) | 1998-09-30 | 2004-08-18 | Bard Peripheral Vascular, Inc. | Delivery mechanism for implantable stent |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US7135009B2 (en) | 2001-04-07 | 2006-11-14 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US20020095203A1 (en) * | 2001-01-18 | 2002-07-18 | Intra Therapeutics, Inc. | Catheter system with spacer member |
US6623491B2 (en) * | 2001-01-18 | 2003-09-23 | Ev3 Peripheral, Inc. | Stent delivery system with spacer member |
US6899727B2 (en) | 2001-01-22 | 2005-05-31 | Gore Enterprise Holdings, Inc. | Deployment system for intraluminal devices |
US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
EA005172B1 (en) | 2001-07-06 | 2004-12-30 | Ангиомед Гмбх Унд Ко.Медицинтехник Кг | Delivery system having a rapid pusher assembly for self-expanding stent, and stent exchange configuration |
US7331984B2 (en) | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
GB0121980D0 (en) * | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
GB0123633D0 (en) | 2001-10-02 | 2001-11-21 | Angiomed Ag | Stent delivery system |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US6790224B2 (en) * | 2002-02-04 | 2004-09-14 | Scimed Life Systems, Inc. | Medical devices |
US9375203B2 (en) | 2002-03-25 | 2016-06-28 | Kieran Murphy Llc | Biopsy needle |
US20030204248A1 (en) * | 2002-03-25 | 2003-10-30 | Murphy Kieran P. | Device viewable under an imaging beam |
US20030181810A1 (en) * | 2002-03-25 | 2003-09-25 | Murphy Kieran P. | Kit for image guided surgical procedures |
US7927368B2 (en) | 2002-03-25 | 2011-04-19 | Kieran Murphy Llc | Device viewable under an imaging beam |
US20040230288A1 (en) * | 2002-04-17 | 2004-11-18 | Rosenthal Arthur L. | Medical devices adapted for controlled in vivo structural change after implantation |
IL149829A (en) * | 2002-05-23 | 2012-10-31 | Ronnie Levi | Medical device having an unravelable portion |
US7329268B2 (en) * | 2002-07-02 | 2008-02-12 | Warsaw Orthopedic, Inc. | Expandable percutaneous sheath |
US20040044404A1 (en) * | 2002-08-30 | 2004-03-04 | Stucke Sean M. | Retention coatings for delivery systems |
US7144422B1 (en) * | 2002-11-13 | 2006-12-05 | Advanced Cardiovascular Systems, Inc. | Drug-eluting stent and methods of making the same |
US7435255B1 (en) | 2002-11-13 | 2008-10-14 | Advnaced Cardiovascular Systems, Inc. | Drug-eluting stent and methods of making |
US7105018B1 (en) * | 2002-12-30 | 2006-09-12 | Advanced Cardiovascular Systems, Inc. | Drug-eluting stent cover and method of use |
EP1589903B1 (en) | 2003-01-15 | 2016-01-13 | Angiomed GmbH & Co. Medizintechnik KG | Trans-luminal surgical device |
US7314480B2 (en) * | 2003-02-27 | 2008-01-01 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery |
US20050049672A1 (en) * | 2003-03-24 | 2005-03-03 | Murphy Kieran P. | Stent delivery system and method using a balloon for a self-expandable stent |
US7198637B2 (en) * | 2003-04-21 | 2007-04-03 | Medtronic Vascular, Inc. | Method and system for stent retention using an adhesive |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US7488343B2 (en) * | 2003-09-16 | 2009-02-10 | Boston Scientific Scimed, Inc. | Medical devices |
EP1696806B1 (en) | 2003-11-21 | 2012-08-29 | Silk Road Medical, Inc. | Apparatus for treating a carotid artery |
US20050131515A1 (en) | 2003-12-16 | 2005-06-16 | Cully Edward H. | Removable stent-graft |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7686841B2 (en) | 2003-12-29 | 2010-03-30 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery system |
US7922753B2 (en) * | 2004-01-13 | 2011-04-12 | Boston Scientific Scimed, Inc. | Bifurcated stent delivery system |
US8012192B2 (en) | 2004-02-18 | 2011-09-06 | Boston Scientific Scimed, Inc. | Multi-stent delivery system |
US8137397B2 (en) * | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
WO2005084584A1 (en) * | 2004-03-02 | 2005-09-15 | Boston Scientific Scimed, Inc. | Medical devices including metallic films and methods for making same |
US20050209670A1 (en) * | 2004-03-02 | 2005-09-22 | Cardiomind, Inc. | Stent delivery system with diameter adaptive restraint |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
CA2502018A1 (en) * | 2004-04-16 | 2005-10-16 | Conor Medsystems, Inc. | Bioresorbable stent delivery system |
US20050273149A1 (en) * | 2004-06-08 | 2005-12-08 | Tran Thomas T | Bifurcated stent delivery system |
US8512388B1 (en) | 2004-06-24 | 2013-08-20 | Advanced Cardiovascular Systems, Inc. | Stent delivery catheter with improved stent retention and method of making same |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8308789B2 (en) * | 2004-07-16 | 2012-11-13 | W. L. Gore & Associates, Inc. | Deployment system for intraluminal devices |
US7765670B2 (en) * | 2004-08-13 | 2010-08-03 | Boston Scientific Scimed, Inc. | Method to simultaneously load and cover self expanding stents |
AU2005289812B2 (en) * | 2004-09-22 | 2010-09-16 | Cook Incorporated | Stent graft with integral side arm |
US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US7691137B2 (en) * | 2004-09-28 | 2010-04-06 | Boston Scientific Scimed, Inc. | Rotatable sheath, assembly and method of manufacture of same |
EP1879520B1 (en) | 2005-05-09 | 2013-03-13 | Angiomed GmbH & Co. Medizintechnik KG | Implant delivery device |
US9480589B2 (en) * | 2005-05-13 | 2016-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis delivery system |
US7670365B2 (en) * | 2005-09-23 | 2010-03-02 | BostonScientific Scimed, Inc. | Secured stent delivery system |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US9375215B2 (en) * | 2006-01-20 | 2016-06-28 | W. L. Gore & Associates, Inc. | Device for rapid repair of body conduits |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
CA2646885A1 (en) | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
ATE458458T1 (en) * | 2006-03-24 | 2010-03-15 | Cordis Corp | SPLIT LOCK RELEASE SYSTEM FOR SELF-EXPANDING STENTS |
US8652192B2 (en) * | 2006-03-31 | 2014-02-18 | St. Jude Medical, Cardiology Division, Inc. | Stent and system and method for deploying a stent |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US20080009799A1 (en) * | 2006-06-30 | 2008-01-10 | Lap Reinder N | Resilient protection sleeve for balloon catheter |
CA2659761A1 (en) | 2006-08-02 | 2008-02-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8062465B1 (en) * | 2006-08-02 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | Methods for improved stent retention |
US20080039920A1 (en) * | 2006-08-08 | 2008-02-14 | Medlogics Device Corporation | Tethered Self-Expanding Stent Delivery System |
EP2049050A1 (en) * | 2006-08-08 | 2009-04-22 | Medlogics Device Corporation | Stent delivery devices, systems & methods |
CA2663271A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
EP2959925B1 (en) | 2006-09-15 | 2018-08-29 | Boston Scientific Limited | Medical devices and methods of making the same |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
ES2368125T3 (en) | 2006-09-15 | 2011-11-14 | Boston Scientific Scimed, Inc. | BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS. |
CA2663303A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Endoprosthesis with adjustable surface features |
WO2008036548A2 (en) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
JP5748407B2 (en) | 2006-11-10 | 2015-07-15 | グローコス コーポレーション | Uveal sclera shunt |
US9622888B2 (en) | 2006-11-16 | 2017-04-18 | W. L. Gore & Associates, Inc. | Stent having flexibly connected adjacent stent elements |
EP2277563B1 (en) | 2006-12-28 | 2014-06-25 | Boston Scientific Limited | Bioerodible endoprostheses and method of making the same |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US7776080B2 (en) * | 2007-04-25 | 2010-08-17 | Abbott Cardiovascualr Systems Inc. | Stent delivery catheter system and method of implanting a self-expanding stent with embolic protection |
JP5290290B2 (en) | 2007-07-18 | 2013-09-18 | シルク・ロード・メディカル・インコーポレイテッド | Method and system for establishing regurgitation of carotid blood flow |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US8545432B2 (en) * | 2009-06-03 | 2013-10-01 | Silk Road Medical, Inc. | System and methods for controlling retrograde carotid arterial blood flow |
US8070798B2 (en) | 2007-07-20 | 2011-12-06 | Josiah Wilcox | Drug eluting medical device and method |
US8252035B2 (en) * | 2007-08-01 | 2012-08-28 | Cappella, Inc. | Device delivery system with two stage withdrawal |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US7981151B2 (en) * | 2007-10-15 | 2011-07-19 | Edwards Lifesciences Corporation | Transcatheter heart valve with micro-anchors |
US8926688B2 (en) | 2008-01-11 | 2015-01-06 | W. L. Gore & Assoc. Inc. | Stent having adjacent elements connected by flexible webs |
ES2821762T3 (en) | 2008-02-05 | 2021-04-27 | Silk Road Medical Inc | Interventional catheter system |
US8915951B2 (en) * | 2008-02-11 | 2014-12-23 | Boston Scientific Scimed, Inc. | Self-expandable stent with a constrictive coating and method of use |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US8414638B2 (en) * | 2008-03-12 | 2013-04-09 | Abbott Cardiovascular Systems Inc. | Method for fabricating a polymer stent with break-away links for enhanced stent retenton |
US9687370B2 (en) * | 2008-05-09 | 2017-06-27 | C.R. Bard, Inc. | Method of loading a stent into a sheath |
GB0815339D0 (en) * | 2008-08-21 | 2008-10-01 | Angiomed Ag | Method of loading a stent into a sheath |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US9750625B2 (en) * | 2008-06-11 | 2017-09-05 | C.R. Bard, Inc. | Catheter delivery device |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8133199B2 (en) | 2008-08-27 | 2012-03-13 | Boston Scientific Scimed, Inc. | Electroactive polymer activation system for a medical device |
US20110190867A1 (en) * | 2008-08-28 | 2011-08-04 | Carlos Vonderwalde | Directional expansion of intraluminal devices |
CA2736649A1 (en) * | 2008-09-10 | 2010-03-18 | Ev3 Inc. | Stents and catheters having improved stent deployment |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
EP4289416A3 (en) * | 2009-05-18 | 2024-01-03 | Dose Medical Corporation | Drug eluting ocular implant |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US20110046709A1 (en) * | 2009-08-18 | 2011-02-24 | Abbott Cardiovascular Systems, Inc. | Methods for implanting a stent using a guide catheter |
EP2475336A1 (en) * | 2009-09-10 | 2012-07-18 | NovoStent Corporation | Vascular prosthesis assembly with retention mechanism and method |
GB0921236D0 (en) | 2009-12-03 | 2010-01-20 | Angiomed Ag | Stent device delivery system and method of making such |
GB0921238D0 (en) | 2009-12-03 | 2010-01-20 | Angiomed Ag | Stent device delivery system and method of making such |
GB0921240D0 (en) | 2009-12-03 | 2010-01-20 | Angiomed Ag | Stent device delivery system and method of making such |
GB0921237D0 (en) | 2009-12-03 | 2010-01-20 | Angiomed Ag | Stent device delivery system and method of making such |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
ES2621343T3 (en) * | 2010-07-20 | 2017-07-03 | Kyoto Medical Planning Co., Ltd. | Stent device |
US8805519B2 (en) | 2010-09-30 | 2014-08-12 | Nevro Corporation | Systems and methods for detecting intrathecal penetration |
US8965482B2 (en) | 2010-09-30 | 2015-02-24 | Nevro Corporation | Systems and methods for positioning implanted devices in a patient |
US9668915B2 (en) | 2010-11-24 | 2017-06-06 | Dose Medical Corporation | Drug eluting ocular implant |
GB201020373D0 (en) | 2010-12-01 | 2011-01-12 | Angiomed Ag | Device to release a self-expanding implant |
FR2970864B1 (en) * | 2011-02-01 | 2015-01-02 | Stentys | DELIVERY SYSTEM FOR A STENT |
CN103501735B (en) | 2011-03-08 | 2016-04-06 | W.L.戈尔及同仁股份有限公司 | For ostomy medical treatment device |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
US10016579B2 (en) * | 2011-06-23 | 2018-07-10 | W.L. Gore & Associates, Inc. | Controllable inflation profile balloon cover apparatus |
US20130116754A1 (en) * | 2011-11-08 | 2013-05-09 | Vivek Sharma | Medical device contact assemblies for use with implantable leads, and associated systems and methods |
US10028854B2 (en) | 2012-02-02 | 2018-07-24 | Covidien Lp | Stent retaining systems |
CA2868341C (en) | 2012-03-26 | 2021-01-12 | Glaukos Corporation | System and method for delivering multiple ocular implants |
US9072590B2 (en) | 2012-12-07 | 2015-07-07 | Abbott Cardiovascular Systems Inc. | Sheaths reducing recoil and loss of retention for polymer scaffolds crimped to balloons |
US9308022B2 (en) | 2012-12-10 | 2016-04-12 | Nevro Corporation | Lead insertion devices and associated systems and methods |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US10905539B2 (en) * | 2013-03-15 | 2021-02-02 | W. L. Gore & Associates, Inc. | Self-expanding, balloon expandable stent-grafts |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
EP2799036A1 (en) * | 2013-04-02 | 2014-11-05 | Biotronik AG | Intraluminal endoprosthesis and method for production thereof |
US9788983B2 (en) | 2013-06-21 | 2017-10-17 | Abbott Cardiovascular Systems Inc. | Removable sheath assembly for a polymer scaffold |
US9675483B2 (en) | 2013-06-21 | 2017-06-13 | Abbott Cardiovascular Systems Inc. | Protective sheath assembly for a polymer scaffold |
US9265935B2 (en) | 2013-06-28 | 2016-02-23 | Nevro Corporation | Neurological stimulation lead anchors and associated systems and methods |
EP3024417B1 (en) * | 2013-07-22 | 2022-12-21 | Atrium Medical Corporation | Graft with expandable region |
DE102013014523A1 (en) * | 2013-09-03 | 2015-03-05 | Phenox Gmbh | Insertion and detachment system for implants |
US10098771B2 (en) | 2013-09-25 | 2018-10-16 | Abbott Cardiovascular Systems Inc. | Clip sheath for a polymer scaffold |
US9913958B2 (en) | 2014-02-28 | 2018-03-13 | Abbott Cardiovascular Systems Inc. | Protective sheaths for medical devices |
US20150313595A1 (en) | 2014-05-02 | 2015-11-05 | W. L. Gore & Associates, Inc. | Anastomosis Devices |
US11439396B2 (en) | 2014-05-02 | 2022-09-13 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
US11712230B2 (en) | 2014-05-02 | 2023-08-01 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
WO2015171911A1 (en) * | 2014-05-09 | 2015-11-12 | Mayo Foundation For Medical Education And Research | Devices and methods for forming stents in vivo |
US20160045302A1 (en) * | 2014-05-16 | 2016-02-18 | Terumo Kabushiki Kaisha | Method and apparatus for treating urethral stricture |
US20150342875A1 (en) | 2014-05-29 | 2015-12-03 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US10299948B2 (en) | 2014-11-26 | 2019-05-28 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US9789321B2 (en) | 2015-04-03 | 2017-10-17 | Nevro Corp. | Couplings for implanted leads and external stimulators, and associated systems and methods |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
CA3022830A1 (en) | 2016-04-20 | 2017-10-26 | Harold Alexander Heitzmann | Bioresorbable ocular drug delivery device |
US10406011B2 (en) * | 2016-04-28 | 2019-09-10 | Medtronic Vascular, Inc. | Implantable medical device delivery system |
US10568752B2 (en) | 2016-05-25 | 2020-02-25 | W. L. Gore & Associates, Inc. | Controlled endoprosthesis balloon expansion |
US10980999B2 (en) | 2017-03-09 | 2021-04-20 | Nevro Corp. | Paddle leads and delivery tools, and associated systems and methods |
US11724075B2 (en) | 2017-04-18 | 2023-08-15 | W. L. Gore & Associates, Inc. | Deployment constraining sheath that enables staged deployment by device section |
US11660218B2 (en) * | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
AU2018346229A1 (en) | 2017-10-06 | 2020-04-30 | Glaukos Corporation | Systems and methods for delivering multiple ocular implants |
USD846738S1 (en) | 2017-10-27 | 2019-04-23 | Glaukos Corporation | Implant delivery apparatus |
EP3758793A4 (en) | 2018-03-29 | 2021-12-08 | Nevro Corp. | Leads having sidewall openings, and associated systems and methods |
CA3126014A1 (en) * | 2019-01-09 | 2020-07-16 | Osf Healthcare System | Endovascular stent graft |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234457A (en) * | 1991-10-09 | 1993-08-10 | Boston Scientific Corporation | Impregnated stent |
US5405378A (en) * | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
US5534007A (en) * | 1995-05-18 | 1996-07-09 | Scimed Life Systems, Inc. | Stent deployment catheter with collapsible sheath |
US5549635A (en) * | 1994-01-24 | 1996-08-27 | Solar, Rita & Gaterud, Ltd. | Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore |
US5735859A (en) * | 1997-02-14 | 1998-04-07 | Cathco, Inc. | Distally attachable and releasable sheath for a stent delivery system |
US5772669A (en) * | 1996-09-27 | 1998-06-30 | Scimed Life Systems, Inc. | Stent deployment catheter with retractable sheath |
US5830217A (en) * | 1996-08-09 | 1998-11-03 | Thomas J. Fogarty | Soluble fixation device and method for stent delivery catheters |
US5843158A (en) * | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
US5899935A (en) * | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
US5928258A (en) * | 1997-09-26 | 1999-07-27 | Corvita Corporation | Method and apparatus for loading a stent or stent-graft into a delivery sheath |
US6036702A (en) * | 1997-04-23 | 2000-03-14 | Vascular Science Inc. | Medical grafting connectors and fasteners |
US6086610A (en) * | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US6126685A (en) * | 1994-06-08 | 2000-10-03 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
US6143016A (en) * | 1997-04-21 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Sheath and method of use for a stent delivery system |
US6290722B1 (en) * | 2000-03-13 | 2001-09-18 | Endovascular Technologies, Inc. | Tacky attachment method of covered materials on stents |
US6336937B1 (en) * | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
US6350277B1 (en) * | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
US20020138129A1 (en) * | 1999-01-22 | 2002-09-26 | Armstrong Joseph R. | Method of producing low profile stent and graft combination |
US20020143381A1 (en) * | 2001-03-27 | 2002-10-03 | Scimed Life Systems, Inc. | Stent with controlled expansion |
US6663664B1 (en) * | 2000-10-26 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with time variable radial force |
US6878161B2 (en) * | 1996-01-05 | 2005-04-12 | Medtronic Vascular, Inc. | Stent graft loading and deployment device and method |
US6899727B2 (en) * | 2001-01-22 | 2005-05-31 | Gore Enterprise Holdings, Inc. | Deployment system for intraluminal devices |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5957974A (en) * | 1997-01-23 | 1999-09-28 | Schneider (Usa) Inc | Stent graft with braided polymeric sleeve |
DE69935716T2 (en) * | 1998-05-05 | 2007-08-16 | Boston Scientific Ltd., St. Michael | STENT WITH SMOOTH ENDS |
-
2001
- 2001-06-29 US US09/897,743 patent/US6629992B2/en not_active Expired - Lifetime
-
2003
- 2003-07-25 US US10/627,791 patent/US20040133261A1/en not_active Abandoned
Patent Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234457A (en) * | 1991-10-09 | 1993-08-10 | Boston Scientific Corporation | Impregnated stent |
US5405378A (en) * | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
US5549635A (en) * | 1994-01-24 | 1996-08-27 | Solar, Rita & Gaterud, Ltd. | Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore |
US6126685A (en) * | 1994-06-08 | 2000-10-03 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
US5534007A (en) * | 1995-05-18 | 1996-07-09 | Scimed Life Systems, Inc. | Stent deployment catheter with collapsible sheath |
US5843158A (en) * | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
US6878161B2 (en) * | 1996-01-05 | 2005-04-12 | Medtronic Vascular, Inc. | Stent graft loading and deployment device and method |
US5830217A (en) * | 1996-08-09 | 1998-11-03 | Thomas J. Fogarty | Soluble fixation device and method for stent delivery catheters |
US5772669A (en) * | 1996-09-27 | 1998-06-30 | Scimed Life Systems, Inc. | Stent deployment catheter with retractable sheath |
US6086610A (en) * | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US5735859A (en) * | 1997-02-14 | 1998-04-07 | Cathco, Inc. | Distally attachable and releasable sheath for a stent delivery system |
US6143016A (en) * | 1997-04-21 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Sheath and method of use for a stent delivery system |
US6036702A (en) * | 1997-04-23 | 2000-03-14 | Vascular Science Inc. | Medical grafting connectors and fasteners |
US5899935A (en) * | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
US5928258A (en) * | 1997-09-26 | 1999-07-27 | Corvita Corporation | Method and apparatus for loading a stent or stent-graft into a delivery sheath |
US6336937B1 (en) * | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
US6350277B1 (en) * | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
US20020138129A1 (en) * | 1999-01-22 | 2002-09-26 | Armstrong Joseph R. | Method of producing low profile stent and graft combination |
US6290722B1 (en) * | 2000-03-13 | 2001-09-18 | Endovascular Technologies, Inc. | Tacky attachment method of covered materials on stents |
US6663664B1 (en) * | 2000-10-26 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with time variable radial force |
US6899727B2 (en) * | 2001-01-22 | 2005-05-31 | Gore Enterprise Holdings, Inc. | Deployment system for intraluminal devices |
US20020143381A1 (en) * | 2001-03-27 | 2002-10-03 | Scimed Life Systems, Inc. | Stent with controlled expansion |
US6878160B2 (en) * | 2001-03-27 | 2005-04-12 | Scimed Life Systems, Inc. | Stent with controlled expansion |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8641751B2 (en) | 2003-04-14 | 2014-02-04 | Tryton Medical, Inc. | Vascular bifurcation prosthesis with multiple linked thin fronds |
US8083791B2 (en) | 2003-04-14 | 2011-12-27 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US8672994B2 (en) | 2003-04-14 | 2014-03-18 | Tryton Medical, Inc. | Prosthesis for treating vascular bifurcations |
US8109987B2 (en) | 2003-04-14 | 2012-02-07 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US8529618B2 (en) | 2003-04-14 | 2013-09-10 | Tryton Medical, Inc. | Ostium support for treating vascular bifurcations |
US7731747B2 (en) | 2003-04-14 | 2010-06-08 | Tryton Medical, Inc. | Vascular bifurcation prosthesis with multiple thin fronds |
US7758630B2 (en) | 2003-04-14 | 2010-07-20 | Tryton Medical, Inc. | Helical ostium support for treating vascular bifurcations |
US8641755B2 (en) | 2003-04-14 | 2014-02-04 | Tryton Medical, Inc. | Prosthesis for treating vascular bifurcations |
US9775728B2 (en) | 2003-04-14 | 2017-10-03 | Tryton Medical, Inc. | Vascular bifurcation prosthesis |
US20070276460A1 (en) * | 2003-04-14 | 2007-11-29 | Davis H R | Helical ostium support for treating vascular bifurcations |
US7972372B2 (en) | 2003-04-14 | 2011-07-05 | Tryton Medical, Inc. | Kit for treating vascular bifurcations |
US20070203571A1 (en) * | 2003-04-14 | 2007-08-30 | Tryton Medical, Inc. | Prosthesis for treating vascular bifurcations |
US20060116748A1 (en) * | 2003-04-14 | 2006-06-01 | Aaron Kaplan | Stepped balloon catheter for treating vascular bifurcations |
US8187314B2 (en) | 2003-04-14 | 2012-05-29 | Tryton Medical, Inc. | Prothesis and deployment catheter for treating vascular bifurcations |
US8876884B2 (en) | 2003-04-14 | 2014-11-04 | Tryton Medical, Inc. | Prosthesis and deployment catheter for treating vascular bifurcations |
US8257432B2 (en) | 2003-04-14 | 2012-09-04 | Tryton Medical, Inc. | Vascular bifurcation prosthesis with at least one frond |
US8252038B2 (en) * | 2004-10-13 | 2012-08-28 | Tryton Medical, Inc. | System for delivering a prosthesis to a luminal OS |
US8926685B2 (en) | 2004-10-13 | 2015-01-06 | Tryton Medical, Inc. | Prosthesis for placement at a luminal OS |
US7972369B2 (en) | 2004-10-13 | 2011-07-05 | Tryton Medical, Inc. | Method for delivering a luminal prosthesis |
US20080015678A1 (en) * | 2004-10-13 | 2008-01-17 | Tryton Medical, Inc. | Prosthesis for placement at a luminal os |
US20090018635A1 (en) * | 2007-07-10 | 2009-01-15 | Boston Scientific Scimed, Inc. | Stent protector |
US20100204770A1 (en) * | 2009-02-10 | 2010-08-12 | Medtronic Vascular, Inc. | Stent Delivery System Permitting in Vivo Stent Repositioning |
US20100234934A1 (en) * | 2009-03-10 | 2010-09-16 | Medtronic Vascular, Inc. | Balloon Deployable Coronary Stent |
US8366763B2 (en) | 2009-07-02 | 2013-02-05 | Tryton Medical, Inc. | Ostium support for treating vascular bifurcations |
US8382818B2 (en) | 2009-07-02 | 2013-02-26 | Tryton Medical, Inc. | Ostium support for treating vascular bifurcations |
US9149373B2 (en) | 2009-07-02 | 2015-10-06 | Tryton Medical, Inc. | Method of treating vascular bifurcations |
US10111767B2 (en) | 2010-10-29 | 2018-10-30 | Abbott Cardiovascular Systems Inc. | Sheaths used in polymer scaffold delivery systems |
US10500072B2 (en) | 2010-11-24 | 2019-12-10 | Poseidon Medical Inc. | Method of treating vascular bifurcations |
US9707108B2 (en) | 2010-11-24 | 2017-07-18 | Tryton Medical, Inc. | Support for treating vascular bifurcations |
WO2012078769A1 (en) * | 2010-12-07 | 2012-06-14 | Northeastern University | Microvascular anastomotic coupler and methods of using the same |
US10232147B2 (en) | 2011-05-27 | 2019-03-19 | Abbott Cardiovascular Systems Inc. | Method for assembling a scaffold-balloon catheter |
US10470907B2 (en) | 2011-06-21 | 2019-11-12 | Abbott Cardiovascular Systems Inc. | Sheaths used with polymer scaffolds |
US10500077B2 (en) | 2012-04-26 | 2019-12-10 | Poseidon Medical Inc. | Support for treating vascular bifurcations |
US9956103B2 (en) | 2013-03-11 | 2018-05-01 | DePuy Synthes Products, Inc. | Stent delivery system and method |
US10792173B2 (en) | 2013-03-11 | 2020-10-06 | DePuy Synthes Products, Inc. | Stent delivery system and method |
US10172734B2 (en) | 2013-03-13 | 2019-01-08 | DePuy Synthes Products, Inc. | Capture tube mechanism for delivering and releasing a stent |
US10786378B2 (en) | 2013-03-13 | 2020-09-29 | DePuy Synthes Products, Inc. | Capture tube mechanism for delivering and releasing a stent |
US10449074B2 (en) | 2014-03-13 | 2019-10-22 | Abbott Cardiovascular Systems Inc. | Striped sheaths for medical devices |
US10433996B2 (en) | 2014-03-13 | 2019-10-08 | Abbott Cardiovascular Systems Inc. | Striped sheaths for medical devices |
WO2017004209A1 (en) * | 2015-06-29 | 2017-01-05 | 480 Biomedical, Inc. | Scaffold loading and delivery systems |
WO2020179697A1 (en) * | 2019-03-06 | 2020-09-10 | 川澄化学工業株式会社 | Stent |
JP7446280B2 (en) | 2019-03-06 | 2024-03-08 | Sbカワスミ株式会社 | Stents and stent placement systems |
Also Published As
Publication number | Publication date |
---|---|
US20020052640A1 (en) | 2002-05-02 |
US6629992B2 (en) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6629992B2 (en) | Sheath for self-expanding stent | |
CA1338303E (en) | Expandable Intraluminal Graft and Apparatus for Implanting an Expandable Intraluminal Graft | |
US5725549A (en) | Coiled stent with locking ends | |
US5951569A (en) | Stent delivery system | |
US6319275B1 (en) | Endolumenal prosthesis delivery assembly and method of use | |
US6174316B1 (en) | Stent delivery system | |
US7118592B1 (en) | Covered stent assembly for reduced-shortening during stent expansion | |
EP0364787B1 (en) | Expandable intraluminal graft | |
US7192440B2 (en) | Implantable stent delivery devices and methods | |
US6565600B2 (en) | Articulated expandable intraluminal stent | |
EP0335341B1 (en) | Expandable intraluminal graft and apparatus for implanting an expandable intraluminal graft | |
US5776141A (en) | Method and apparatus for intraluminal prosthesis delivery | |
EP2328522B1 (en) | Directional expansion of intraluminal devices | |
US6752825B2 (en) | Nested stent apparatus | |
EP1782761A1 (en) | Prosthesis having a plurality of stent segments and an apparatus for delivering the same | |
US20050119731A1 (en) | Bifurcated stent and delivery system | |
US20080015610A1 (en) | System for delivering a prosthesis to a luminal os | |
JPH1057502A (en) | Automatic expansive stent delivery device | |
US20100241069A1 (en) | Ostial lesion stent delivery system | |
JPH11347133A (en) | Endoluminal supporting assembly with end cap | |
US20070225792A1 (en) | Conformable vascular prosthesis delivery system | |
WO2001017459A1 (en) | System for removably securing a stent on a catheter assembly and method of use | |
MXPA06005017A (en) | Treatment of vascular bifurcations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |